rss
J Clin Pathol 2003;56:249-253 doi:10.1136/jcp.56.4.249
  • Review

The clinical relevance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia

  1. J Moppett,
  2. G A A Burke,
  3. C G Steward,
  4. A Oakhill,
  5. N J Goulden
  1. Department of Paediatric Oncology and Haematology, Bristol Royal Hospital for Children, Bristol BS2 8JD, UK
  1. Correspondence to:
 Dr N J Goulden, Department of Paediatric Oncology and Haematology, Bristol Royal Hospital for Children, Upper Maudlin Street, Bristol BS2 8JD, UK; 
 nick.goulden{at}ubht.swest.nhs.uk
  • Accepted 14 October 2002

Abstract

Risk directed treatment forms a central component of modern protocols for childhood acute lymphoblastic leukaemia (ALL). A review of recent studies of minimal residual disease (MRD) analysis shows that it is a powerful prognostic factor in both first line and relapse treatment. However, the value of MRD analysis is both time point and protocol specific, and the threshold for MRD detection of the technique used impacts upon the results obtained. MRD analysis does have a useful role to play in the risk directed treatment of childhood ALL, and this is currently being investigated in large prospective studies.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.